Stock Market

Dow, S&P 500, Nasdaq futures climb as Trump stokes hopes a US-China trade deal is near


US stock futures climbed on Monday amid promising signs that a US-China trade deal will cap President Trump’s long-awaited meeting with China’s President Xi later this week.

Dow Jones Industrial Average futures (YM=F) moved up roughly 0.5%, or around 200 points, while those on the S&P 500 (ES=F) jumped 0.8%. Contracts on the tech-heavy Nasdaq 100 (NQ=F) led gains, up 1.3%.

Wall Street is in an upbeat mood as it gears up for a pivotal week featuring the Federal Reserve’s interest-rate decision and a barrage of Big Tech earnings, as well as Thursday’s high-stakes meeting between Trump and Xi.

The optimism follows a banner week that saw all three major indexes close at all-time highs on Friday. Stocks are eyeing further records after US and China officials signaled that weekend talks had paved the way for a breakthrough in the trade standoff.

“I think we have a very successful framework for the leaders to discuss on Thursday,” Treasury Secretary Scott Bessent told reporters on Sunday. At the same time, Beijing hailed a “preliminary consensus” on resolving key issues, helping ease trade-war worries sparked by recent heightened tensions.

“I’ve got a lot of respect for President Xi and I think we’re going to come away with a deal,” Trump told reporters on Air Force One en route to Japan from Malaysia.

Meanwhile, markets are all but certain the Fed will cut rates on Wednesday when policymakers wrap up their two-day meeting this week. Cooler-than-expected inflation data — the US shutdown-delayed Consumer Price Index report — bolstered the case for easing on Friday.

That decision lands alongside another big potential catalyst, the arrival of quarterly earnings from the “Magnificent Seven” tech megacaps. Microsoft (MSFT), Alphabet (GOOG), and Meta (META) are set to report third-quarter results on Wednesday, with Apple (AAPL) and Amazon (AMZN) scheduled a day later.

LIVE 7 updates

  • Huntington Bank to buy Cadence for $7.4 billion, WSJ reports

    Huntington (HBAN) has reached an agreement to buy the regional bank Cadence Bank (CADE) in an all-stock deal worth $7.4 billion, the Wall Street Journal reported on Monday.

    Huntington Bancshares’ stock fell 5%, while Cadence shares increased by 3% in premarket trading.

    The acquisition expands Huntington’s presence in the Southern US, bringing the bank into 21 states, and marks the latest deal in a wave of regional bank consolidations as midsize financial institutions look to compete with megabanks. Other M&A activity announced this year includes Fifth Third’s (FITB) acquisition of Comerica (CMA) and Pinnacle Financial Partners’ (PNFP) merger with Synovus (SNV).

  • Jenny McCall

    Good morning. Here’s what’s happening today.

  • Jenny McCall

    Premarket movers: Dr Pepper, GameStop, and rare earth stocks

    Keurig Dr Pepper Inc. (KDP) stock rose 5% before the bell after raising its full-year outlook on Monday. The beverage maker now expects fiscal 2025 constant currency net sales growth to be in a high-single-digit range.

    GameStop (GME) stock gained 6% in premarket trading on Monday. The video-game retailer is benefiting from the meme stock frenzy, which boosted Beyond Meat (BYND) last week.

    US rare earth stocks fell on Monday in premarket trading following US Treasury Secretary Scott Bessent’s comments that China will delay export restrictions on rare earth materials. USA Rare Earth (USAR) stock fell 6% in premarket trading on Monday. Trilogy Metals (TMQ) and MP Materials (MP) retreated by 4% and Energy Fuels (UUUU) dropped 3% before the bell on Monday.

  • Big Tech earnings, a crucial Fed meeting, and a Trump-Xi sit-down: What to watch this week

    Yahoo Finance’s Jake Conley takes a look at a big week ahead:

    Read more here.

  • Avidity stock surges after Novartis seals $12 billion buy

    Novartis has agreed to buy Avidity Biosciences for about $12 billion in cash, seeking to bolster its range of treatments for rare muscle disorders.

    Shares in the US biotech soared over 40% in premarket after the Swiss drugmaker’s announcement.

    Reuters reports:

    Read more here.

  • Asian shares rally with Nikkei topping 50,000

    AP Finance reports:

    Read more here.

  • Gold continues to fall as US-China trade deal reduces need for havens

    Bloomberg reports:

    Read more here.



Source link

Leave a Response